Skip to content

OraQuick HCV Rapid Antibody Test

by OraSure Technologies, Inc. United States EUDAMED

Ref 1001-0270 EMDN W0105090202

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-20608337000560 Basic UDI-DIDate15 May 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
OraQuick HCV Rapid Antibody Test, 25 Count
Model / Reference
1001-0270
Primary DI / UDI-DI
20608337000560
Basic UDI-DI
B-20608337000560
EMDN Code
W0105090202 Hcv antibody -rt & poc
Device Class
Class IVD Annex II List A
Market of Registration
Bulgaria

Manufacturer details

EUDAMED SRN
US-MF-000009941
Authorised representative
QbD RepS BV BE-AR-000000040

Other devices from OraSure Technologies, Inc.

See all devices from OraSure Technologies, Inc. →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Microbial Substances
  • Near-Patient Testing
  • Professional Testing
Other properties (6)
  • Sterile: No
  • Human Tissues: No
  • Reagent: No
  • Self Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED e91b003a-6211-44cc-ab27-92218fc58aba 61 fields · synced 24 Oct 2026